
Quarterly biopharma, diagnostics, and medtech M&A value worldwide 2015-2020
In Q4 2020, some 83 billion U.S. dollars worth of M&A deals were done in the biopharma, diagnostics, and medtech industries. This statistic illustrates the quarterly value of M&A deals involving biopharma therapeutics and platforms, diagnostics, and medtech (also digital health) companies from 2015 to 2020.